The EU is the second market for the drug after the US, where it was approved under the Attruby brand name last November, on ...

Recognising that challenge, AstraZeneca's rare disease unit Alexion has launched an interactive storybook that can help ...

Roche's sale of InterMune and Esbriet in the US comes as Boehringer revealed its own follow-up play in the IPF, category, ...

Super Bowl ads aren’t just entertainment; they’re cultural barometers. They reflect what resonates with audiences, what ...

Novartis has agreed to buy Anthos Therapeutics from private equity firm Blackstone for $3.1 billion, adding a drug in ...

Martin, who was appointed as Inspector General for the USAID towards the end of 2023 by former President Joe Biden, was dismissed via an email from Trent Morse, deputy director of the White House ...

This can help individuals feel fuller for longer and can promote weight loss. When measured by traditional weight loss ...

Merck said in a brief statement that discussions are "advanced" but noted that "critical conditions have yet to be met" ...

The two positive studies mean that Boehringer can now seek approval for nerandomilast with a broad label claim in pulmonary ...

Shares in Pliant Therapeutics plunged in after-hours trading after the US biotech revealed that it has paused a phase 2b/3 ...

In a notice, the NIH said that indirect costs accounted for around $9 billion of its $35 billion funding spend in fiscal 2023 ...

The downsizing of health federal agencies comes after Trump threatened to pull the US out of the World Health Organization ...